This page shows the latest US drug prices news and features for those working in and with pharma, biotech and healthcare.
Soaring drug prices had been a key issue for the Trump administration, with the outgoing US president issuing several executive orders in late 2020 aimed at lowering prices. ... Drug pricing will also be a focus of the incoming President-elect, Joe Biden,
AbbVie. They also highlighted AbbVie’s use of controversial “rebate walls” around its blockbuster immunology products – including Humira and Skyrizi – which the groups say “lead to higher prescription drug prices” and ... This in turn could
Reignites criticism of high drug prices in the US. Former Sandoz executive Hector Armando Kellum has pled guilty to charges levied against him, which allege he participated in a price-fixing ... President Donald Trump, as well as Democratic presidential
Plans to have its first drug on the market in just five years. ... A new US start-up says it has a plan to completely revamp the approach to drug development, allowing to launch drugs more quickly and at a lower cost.
It will be led by Allergan’s current senior vice president, US medical aesthetics Carrie Strom, who will go on to assume the new roles of senior vice president of AbbVie ... areas, and also could cause high drug prices in the US to continue or worsen.
range. The price increases come amid intense public and political discourse over prescription drug prices in the US. ... The draft guidance would allow states in the US to import prescription drugs from Canada, as part of cost-saving efforts to combat
More from news
Approximately 12 fully matching, plus 29 partially matching documents found.
US drug prices are often used as a direct or indirect reference for products sold in BRIC markets. ... As a result US government efforts to reduce pharmaceutical prices is likely to have an impact.”.
exclusivity ends. Thus in the US we see generic drug prices often reduced by as much as 90% or more, with uptake then rising accordingly. ... As prices in the US continue to spiral out of control, we can only look on with envy.
Why it’s so hard for the US to curb runaway drug prices. ... Something that is seldom mentioned in the drug pricing debate: the US has a greater number of generics sold at cheaper prices than any other country in the world, with 90%
The three-hour evidence session also bore some resemblance to the recent interrogation of seven big pharma CEOs by a US Senate committee enquiry into US drug prices, albeit with just ... were ‘freeloading’ while high US prices provide the incentive
US drug prices. In other news from the US, there are now expectations of a legislative stalemate following the mid‐term elections in early November. ... It is worth remembering that there are still a few areas where both political parties are prepared
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Hello we’re Triducive. We’re a healthcare strategy and value consultancy that provides expert and insight-driven solutions that strengthen and realise...